-
Mashup Score: 16What are Natural Killer Cells and How Do They Fight Cancer? - 3 day(s) ago
Natural killer (NK) cells have specialized roles as part of the immune system and have shown potential for being used in cancer immunotherapy.
Source: blog.dana-farber.orgCategories: General Medicine NewsTweet
-
Mashup Score: 22A Year of Advances in Genitourinary Cancer - 10 day(s) ago
Published: February 6, 2025Written by: Beth DoughertyMedically Reviewed By: Atish Choudhury, MD, PhD, Toni Choueiri, MD, and Mark Pomerantz, MDDana-Farber’s genitourinary cancer team is devoted to research that will advance patient care and improve patient’s lives. Recently, that research — all of it years in the making — has paid off with major achievements. This … Read more
Source: blog.dana-farber.orgCategories: General Medicine NewsTweet-
“Our focused efforts are yielding results that are helping patients today and guiding our research towards more advances in the future,” says @DrChoueiri. Learn about the research advancements @DanaFarber_GU has made this past year. https://t.co/vIyAzrKZKg
-
-
Mashup Score: 8Ultraprocessed Foods: Science Facts and Shopping Tips | Dana-Farber Cancer Institute - 11 day(s) ago
At Dana-Farber, our experts are looking at ultraprocessed foods and their association with cancer risks from multiple angles.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
You might have heard the buzz about ultraprocessed foods being unhealthy. But what are they, exactly? And are they really all that bad? #healthyeating #cleaneating #cancerprevention #danafarber https://t.co/Io3yfzdBvr
-
-
Mashup Score: 25Understanding the Spread of Science Misinformation - 12 day(s) ago
Misinformation about science and health can lead individuals to make ill-informed decisions that aren’t in their best interest.
Source: blog.dana-farber.orgCategories: General Medicine NewsTweet-
False health information can lead to confusion and poor decisions. Vish Viswanath, PhD, shares insights on how to spot misinformation and find trusted sources. Swipe for tips and learn more here: https://t.co/Vp1Bvr8R7X https://t.co/TVOd1A4jIl
-
-
Mashup Score: 13AI Learns Genomic “Language” to Advance Cancer Treatment - 13 day(s) ago
Explore the role of AI in cancer research and its impact on understanding the human genome. Discover groundbreaking advancements.
Source: blog.dana-farber.orgCategories: General Medicine NewsTweet-
New research led by Bradley Bernstein and published in @CellPressNews's Cell Genomics presents an AI transformer model developed in collaboration with @Google Advanced Sciences which can predict gene expression in unseen cell types. https://t.co/34eU13oS4g https://t.co/1R2Q38oXXG
-
-
Mashup Score: 3Persistence Pays Off for Patient with Lung Cancer - 17 day(s) ago
A clinical trial gave a patient new options with a targeted KRAS drug for stage IV lung cancer. Learn about this groundbreaking treatment.
Source: blog.dana-farber.orgCategories: General Medicine NewsTweet-
For years, Rosemary Conway held onto hope for a treatment that could target the KRASG12D mutation driving her lung cancer. In 2023, a clinical trial gave her that chance. Read more about Rosemary’s story. https://t.co/MdawxWrD2b
-
-
Mashup Score: 0Potential targeted therapy for pediatric brain cancer identified by Dana-Farber/Boston Children's team | Dana-Farber Cancer Institute - 1 month(s) ago
An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high-grade glioma. They found that the drug, already FDA-approved for certain adult cancers, was generally safe and resulted in tumor reduction visible on brain scans, as well as clinical improvement, in 3 out of 7 patients.
Source: www.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
Researchers from the lab of Mariella Filbin, MD, PhD, in collaboration with @umichmedicine and the Medical University of Vienna, explore a potential new use for Avapritinib in treating aggressive gliomas. Learn more: https://t.co/oNl3Stk0ae
-
-
Mashup Score: 0Dana-Farber and Gustave Roussy announce 2025 Transatlantic Exchange scientific program to focus on Radioligand Therapy | Dana-Farber Cancer Institute - 1 month(s) ago
Dana-Farber Cancer Institute and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the Fourth Transatlantic Exchange in Oncology Conference topic will be “Radiopharmaceutical Therapy Meets Oncology.” The meeting, supported by L’Institut Servier, will be held in-person on March 19, 2025, at Hyatt Regency Etoile Hotel and livestreamed.
Source: www.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
Yesterday, @DrChoueiri and Karim Fizazi, MD, PhD, kicked off The Fourth Transatlantic Exchange in Oncology: Radiopharmaceutical Therapy Meets Oncology. Learn more about the collaborative event with @GustaveRoussy: https://t.co/gGSkI5b6oq https://t.co/PSNVg8Eybk
-
-
Mashup Score: 6
Dana-Farber researchers are evaluating strategies to improve the CAR T-cell product to enhance efficacy and safety, study novel antigens, and use these therapies in earlier disease states, including newly-diagnosed MM and high-risk smoldering myeloma.
Source: www.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
.@OmarNadeemMD, shares an update on efforts to continually improve CAR T-cell therapy as a treatment option for patients with #multiplemyeloma. #mmsm https://t.co/1QVt8cD0Ca https://t.co/niD0hhMGvI
-
-
Mashup Score: 8Multiple Myeloma Treatment Advances: Five Things to Know - 1 month(s) ago
For patients with multiple myeloma, an incurable cancer that affects blood plasma cells, there are many new options for treatment.
Source: blog.dana-farber.orgCategories: General Medicine News, Oncologists1Tweet-
There are many new treatment options for patients with multiple myeloma that are producing better, increasingly long-lasting outcomes. What do you need to know about these advancements? Learn more: https://t.co/G1wDxIkbNa
-
The body has secret cancer fighters—Natural Killer (NK) cells. These immune cells are the body’s first responders when cancer or infection develops, and now, scientists are testing ways to supercharge NK cells for even greater impact. Learn more: https://t.co/IynfaIQnRY https://t.co/cVkCETvDAJ